We Think Some Shareholders May Hesitate To Increase 10x Genomics, Inc.'s (NASDAQ:TXG) CEO Compensation

Yahoo FinanceJun 5 06:56 ET

Unveiling 9 Analyst Insights On 10x Genomics

Ratings for 10x Genomics (NASDAQ:TXG) were provided by 9 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.The following table provides a quick overview of their

BenzingaJun 3 14:01 ET

Express News | Jefferies Initiates Coverage On 10x Genomics With Hold Rating, Announces Price Target of $24

BenzingaJun 3 13:59 ET

Express News | 10X Genomics Inc : Jefferies Initiates Coverage With Hold Rating; Price Target $24

ReutersJun 3 01:45 ET

We're Not Worried About 10x Genomics' (NASDAQ:TXG) Cash Burn

We can readily understand why investors are attracted to unprofitable companies. For example, biotech and mining exploration companies often lose money for years before finding success with a new tr

Simply Wall StMay 30 09:33 ET

10x Genomics Launches 5,000-Plex Gene Panel for Xenium

New Xenium Prime 5K Pan-Tissue and Pathways panel increases plex by an order of magnitude and delivers industry-leading speed and throughput PLEASANTON, Calif., May 29, 2024 /PRNewswire/ -- 10x Genom

PR NewswireMay 29 16:05 ET